AngioDynamics Stock Analysis

ANGO Stock  USD 9.64  0.18  1.90%   
AngioDynamics price decline over the last few months could raise concerns from insiders as the firm is trading at a share price of 9.64 on 314,659 in volume. The company directors and management were not very successful in positioning the firm resources to exploit market volatility in May. However, diversifying your holdings with AngioDynamics or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.35. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the AngioDynamics partners.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
The main objective of AngioDynamics stock analysis is to determine its intrinsic value, which is an estimate of what AngioDynamics is worth, separate from its market price. There are two main types of AngioDynamics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AngioDynamics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AngioDynamics' stock to identify patterns and trends that may indicate its future price movements.
The AngioDynamics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AngioDynamics is usually not traded on Christmas Day, Thanksgiving Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ). AngioDynamics Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AngioDynamics' ongoing operational relationships across important fundamental and technical indicators.

AngioDynamics Stock Analysis Notes

About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. AngioDynamics has Price/Earnings To Growth (PEG) ratio of 1.87. The entity recorded a loss per share of 0.96. The firm had not issued any dividends in recent years. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people. For more info on AngioDynamics please contact Joseph DeVivo at 518 795 1400 or go to

AngioDynamics Quarterly Cost of Revenue

40.21 Million

AngioDynamics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. AngioDynamics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding AngioDynamics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
AngioDynamics generated a negative expected return over the last 90 days
AngioDynamics has high historical volatility and very poor performance
AngioDynamics is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 316.22 M. Net Loss for the year was (26.55 M) with profit before overhead, payroll, taxes, and interest of 164.93 M.
AngioDynamics currently holds about 24.56 M in cash with (7.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
AngioDynamics has a poor financial position based on the latest SEC disclosures
Over 97.0% of the company shares are held by institutions such as insurance companies
Latest headline from Is the Options Market Predicting a Spike in AngioDynamics Stock

AngioDynamics Upcoming and Recent Events

Earnings reports are used by AngioDynamics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to AngioDynamics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
11th of July 2023
Upcoming Quarterly Report
5th of October 2023
Next Financial Report
31st of May 2023
Next Fiscal Quarter End
11th of July 2023
Next Fiscal Year End
28th of February 2023
Last Quarter Report
31st of May 2022
Last Financial Announcement

AngioDynamics Largest EPS Surprises

Earnings surprises can significantly impact AngioDynamics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates
View All Earnings Estimates

AngioDynamics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. AngioDynamics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that AngioDynamics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial AngioDynamics specific information freely available to individual and institutional make a timely investment decision.
17th of April 2023
Financial Statements and Exhibits. Regulation FD Disclosure
30th of March 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition
6th of March 2023
Financial Statements and Exhibits. Regulation FD Disclosure
27th of February 2023
Other Events
10th of February 2023
Unclassified Corporate Event
9th of February 2023
Unclassified Corporate Event
6th of February 2023
Unclassified Corporate Event
3rd of February 2023
Unclassified Corporate Event

AngioDynamics Thematic Classifications

In addition to having AngioDynamics stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters Idea
Cancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

AngioDynamics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 378.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AngioDynamics's market, we take the total number of its shares issued and multiply it by AngioDynamics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AngioDynamics Profitablity

AngioDynamics' profitability indicators refer to fundamental financial ratios that showcase AngioDynamics' ability to generate income relative to its revenue or operating costs. If, let's say, AngioDynamics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AngioDynamics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AngioDynamics' profitability requires more research than a typical breakdown of AngioDynamics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.07) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.07.
Last ReportedProjected for 2023
Return on Investment(7.20) (7.39) 
Return on Average Assets(0.0432) (0.0466) 
Return on Average Equity(0.06) (0.06) 
Return on Invested Capital(0.21) (0.23) 
Return on Sales(0.08) (0.09) 

Management Efficiency

AngioDynamics has return on total asset (ROA) of (0.0283) % which means that it has lost $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.09) %, meaning that it created substantial loss on money invested by shareholders. AngioDynamics' management efficiency ratios could be used to measure how well AngioDynamics manages its routine affairs as well as how well it operates its assets and liabilities. As of 2nd of June 2023, Return on Investment is likely to drop to -7.39. In addition to that, Return on Average Assets is likely to drop to -0.05. AngioDynamics Net Current Assets as percentage of Total Assets are very stable at the moment as compared to the past year. AngioDynamics reported last year Net Current Assets as percentage of Total Assets of 14.36. As of 2nd of June 2023, Tangible Assets Book Value per Share is likely to grow to 5.24, while Revenue to Assets are likely to drop 0.46.
Last ReportedProjected for 2023
Book Value per Share 9.79  11.27 
Enterprise Value over EBIT(23.40) (24.02) 
Enterprise Value over EBITDA 346.94  374.33 
Price to Book Value 2.06  1.74 
Tangible Assets Book Value per Share 4.60  5.24 
Enterprise Value876.7 M823.8 M
Tangible Asset Value179.4 M193.4 M
The analysis of AngioDynamics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze AngioDynamics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of AngioDynamics Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Long Term Debt Total
25 M
Non Current Liabilities Total
53.9 M
Short Long Term Debt Total
33.8 M
Interest Expense
688 K
Total Operating Expenses
183.9 M

Technical Drivers

As of the 2nd of June, AngioDynamics shows the risk adjusted performance of (0.05), and Mean Deviation of 2.2. AngioDynamics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for AngioDynamics, which can be compared to its rivals. Please confirm AngioDynamics variance, as well as the relationship between the value at risk and skewness to decide if AngioDynamics is priced correctly, providing market reflects its regular price of 9.64 per share. Given that AngioDynamics has jensen alpha of (0.25), we suggest you to validate AngioDynamics's prevailing market performance to make sure the company can sustain itself at a future point.

AngioDynamics Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to AngioDynamics changes than the simple moving average.

AngioDynamics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AngioDynamics insiders, such as employees or executives, is commonly permitted as long as it does not rely on AngioDynamics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AngioDynamics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

AngioDynamics Technical and Predictive Indicators

AngioDynamics Forecast Models

AngioDynamics' time-series forecasting models are one of many AngioDynamics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AngioDynamics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About AngioDynamics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AngioDynamics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AngioDynamics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AngioDynamics. By using and applying AngioDynamics Stock analysis, traders can create a robust methodology for identifying AngioDynamics entry and exit points for their positions.
Last ReportedProjected for 2023
Operating Margin(10.35) (11.17) 
EBITDA Margin 0.0072  0.007389 
Gross Margin 0.60  0.62 
Profit Margin(0.08) (0.08) 

Current AngioDynamics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AngioDynamics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. AngioDynamics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
AngioDynamics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most AngioDynamics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AngioDynamics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AngioDynamics, talking to its executives and customers, or listening to AngioDynamics conference calls.
AngioDynamics Analyst Advice Details

AngioDynamics Stock Analysis Indicators

AngioDynamics stock analysis indicators help investors evaluate how AngioDynamics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading AngioDynamics shares will generate the highest return on investment. By understating and applying AngioDynamics stock analysis, traders can identify AngioDynamics position entry and exit signals to maximize returns.
Begin Period Cash Flow48.2 M
Total Stockholder Equity424.5 M
Property Plant And Equipment Net45 M
Cash And Short Term Investments28.8 M
Cash28.8 M
50 Day M A9.5506
Net Interest Income-688 K
Total Current Liabilities74.3 M
Forward Price Earnings1111.1111
Investments-11.4 M
Common Stock Total Equity380 K
Interest Expense688 K
Stock Based Compensation10.7 M
Common Stock Shares Outstanding39 M
Total Cashflows From Investing Activities-19.3 M
Tax Provision-3.4 M
Other Current Assets2.2 M
Accounts Payable28 M
Net DebtM
Other Operating Expenses334.4 M
Non Current Assets Total409.4 M
Liabilities And Stockholders Equity552.8 M
Non Currrent Assets Other-5.1 M
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AngioDynamics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.